CoChat

In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer

Open access
Kather, Jakob Nikolas, Poleszczuk, Jan, Suarez-Carmona, Meggy, Krisam, Johannes, Charoentong, Pornpimol, Valous, Nektarios A., Weis, Cleo-Aron, Tavernar, Luca, Leiss, Florian, Herpel, Esther, Klupp, Fee, Ulrich, Alexis, Schneider, Martin, Marx, Alexander, Jäger, Dirk, Halama, Niels · 2017 · Cancer Research
Cited by 100

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Despite the fact that the local immunological microenvironment shapes the prognosis of colorectal cancer, immunotherapy has shown no benefit for the vast majority of colorectal cancer patients. A better understanding of the complex immunological interplay within the microenvironment is required. In this study, we utilized wet lab migration experiments and quantitative histological data of human colorectal cancer tissue samples (n = 20) including tumor cells, lymphocytes, stroma, and necrosis to generate a multiagent spatial model. The resulting data accurately reflected a wide range of situations of successful and failed immune surveillance. Validation of simulated tissue outcomes on an independent set of human colorectal cancer specimens (n = 37) revealed the model recapitulated the spatial layout typically found in human tumors. Stroma slowed down tumor growth in a lymphocyte-deprived environment but promoted immune escape in a lymphocyte-enriched environment. A subgroup of tumors with less stroma and high numbers of immune cells showed high rates of tumor control. These findings were validated using data from colorectal cancer patients (n = 261). Low-density stroma and high lymphocyte levels showed increased overall survival (hazard ratio 0.322, P = 0.0219) as compared with high stroma and high lymphocyte levels. To guide immunotherapy in colorectal cancer, simulation of immunotherapy in preestablished tumors showed that a complex landscape with optimal stroma permeabilization and immune cell activation is able to markedly increase therapy response in silico. These results can help guide the rational design of complex therapeutic interventions, which target the colorectal cancer microenvironment. Cancer Res; 77(22); 6442–52. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-17-2006

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 100

Metadata

Authors
Kather, J. N., Poleszczuk, J., Suarez-Carmona, M., Krisam, J., Charoentong, P., Valous, N. A., Weis, C.-A., Tavernar, L., Leiss, F., Herpel, E., Klupp, F., Ulrich, A., Schneider, M., Marx, A., Jäger, D., & Halama, N.
Venue
Cancer Research
Published
2017-11-14
Volume
77
Issue
22
Pages
6442-6452
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2755261245
Cited by
100
References
7
FWCI
6.97
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-17-2006
The paper
Kather, J. N., Poleszczuk, J., Suarez-Carmona, M., Krisam, J., Charoentong, P., Valous, N. A., Weis, C.-A., Tavernar, L., Leiss, F., Herpel, E., Klupp, F., Ulrich, A., Schneider, M., Marx, A., Jäger, D., & Halama, N. (2017). In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-17-2006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.